Selenium and iron, two elemental rivals in the ferroptotic death process
Selenium and iron, two elemental rivals in the ferroptotic death process |
https://doi.org/10.18632/oncotarget.25295
Irina Ingold,
and Marcus Conrad
|
22241-22242 |
Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials
Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials |
https://doi.org/10.18632/oncotarget.25155
Jon F. Wilkins,
Vincent L. Cannataro,
Brian Shuch,
and Jeffrey P. Townsend
|
22243-22253 |
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy |
https://doi.org/10.18632/oncotarget.24962
Fabian D. Mairinger,
Jan Schmeller,
Sabrina Borchert,
Michael Wessolly,
Elena Mairinger,
Jens Kollmeier,
Thomas Hager,
Thomas Mairinger,
Daniel C. Christoph,
Robert F.H. Walter,
Wilfried E.E. Eberhardt,
Till Plönes,
Jeremias Wohlschlaeger,
Bharat Jasani,
Kurt Werner Schmid,
and Agnes Bankfalvi
|
22254-22268 |
Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats
Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats |
https://doi.org/10.18632/oncotarget.25170
Alessandra Consonni,
Chiara Cordiglieri,
Elena Rinaldi,
Roberta Marolda,
Ilaria Ravanelli,
Elena Guidesi,
Marina Elli,
Renato Mantegazza,
and Fulvio Baggi
|
22269-22287 |
Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203
Identification and functional characterization of circRNA-0008717 as an oncogene in osteosarcoma through sponging miR-203 |
https://doi.org/10.18632/oncotarget.23466
Xiang Zhou,
Dimple Natino,
Zili Qin,
Dong Wang,
Zhen Tian,
Xuan Cai,
Bo Wang,
and Xijing He
|
22288-22300 |
Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner
Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner |
https://doi.org/10.18632/oncotarget.24737
Frederick Zhehao Zhang,
Derek Hoi-Hang Ho,
and Roger Hoi-Fung Wong
|
22301-22315 |
Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment
Tumor targeting with pH-responsive poly(2-oxazoline)-based nanogels for metronomic doxorubicin treatment |
https://doi.org/10.18632/oncotarget.24806
Doerte Hoelzer,
Meike N. Leiske,
Matthias Hartlieb,
Tanja Bus,
David Pretzel,
Stephanie Hoeppener,
Kristian Kempe,
René Thierbach,
and Ulrich S. Schubert
|
22316-22331 |
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer |
https://doi.org/10.18632/oncotarget.24900
Giandomenico Roviello,
Silvia Paola Corona,
Andrea Giovanni Multari,
Giovanni Paganini,
Giorgio Chiriacò,
Raffaele Conca,
Roberto Petrioli,
Daniele Generali,
Pietro Rosellini,
and Michele Aieta
|
22332-22339 |
LSCC SNP variant regulates SOX2 modulation of VDAC3
LSCC SNP variant regulates SOX2 modulation of VDAC3 |
https://doi.org/10.18632/oncotarget.24918
Jacqueline Chyr,
Dongmin Guo,
and Xiaobo Zhou
|
22340-22352 |
BRCAmut and “founder effect”: a prospective study in a single academic institution
BRCAmut and “founder effect”: a prospective study in a single academic institution |
https://doi.org/10.18632/oncotarget.24959
Vera Loizzi,
Ettore Cicinelli,
Francesco Santamaria,
Ferdinando Murgia,
Valentina Minicucci,
Leonardo Resta,
Nicoletta Resta,
Maria Iole Natalicchio,
Girolamo Ranieri,
and Gennaro Cormio
|
22353-22358 |
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker |
https://doi.org/10.18632/oncotarget.25009
Rachel A. Levin,
Maria E. Lund,
Quach Truong,
Angela Wu,
Neal D. Shore,
Daniel R. Saltzstein,
Raoul S. Concepcion,
Thomas A. Paivanas,
Arletta van Breda,
Jennifer Beebe-Dimmer,
Julie J. Ruterbusch,
Sandra Wissmueller,
Douglas H. Campbell,
and Bradley J. Walsh
|
22359-22367 |
Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker
Outcomes prediction in pre-operative radiotherapy locally advanced rectal cancer: leucocyte assessment as immune biomarker |
https://doi.org/10.18632/oncotarget.25023
Alexis Vallard,
Max-Adrien Garcia,
Peng Diao,
Sophie Espenel,
Guy de Laroche,
Jean-Baptiste Guy,
Majed Ben Mrad,
Chloé Rancoule,
David Kaczmarek,
Thierry Muron,
Gregoire Pigné,
Jack Porcheron,
Michel Peoc'h,
Jean-Marc Phelip,
Julien Langrand-Escure,
and Nicolas Magné
|
22368-22382 |
Atomistic molecular dynamics simulations of bioactive engrailed 1 interference peptides (EN1-iPeps)
Atomistic molecular dynamics simulations of bioactive engrailed 1 interference peptides (EN1-iPeps) |
https://doi.org/10.18632/oncotarget.25025
Neha S. Gandhi,
Pilar Blancafort,
and Ricardo L. Mancera
|
22383-22397 |
Intrauterine hyperglycemia induces intergenerational Dlk1-Gtl2 methylation changes in mouse placenta
Intrauterine hyperglycemia induces intergenerational Dlk1-Gtl2 methylation changes in mouse placenta |
https://doi.org/10.18632/oncotarget.23976
Ying Jiang,
Yi-Chen Yu,
Guo-Lian Ding,
Qian Gao,
Feng Chen,
and Qiong Luo
|
22398-22405 |
Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models
Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models |
https://doi.org/10.18632/oncotarget.25032
Stephan Niland,
Dorde Komljenovic,
Jadranka Macas,
Thilo Bracht,
Tobias Bäuerle,
Stefan Liebner,
and Johannes A. Eble
|
22406-22422 |
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia
MYB induces the expression of the oncogenic corepressor SKI in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.25051
Miriam Frech,
Sabine Teichler,
Christine Feld,
Caroline Bouchard,
Hannah Berberich,
Katharina Sorg,
Marco Mernberger,
Lars Bullinger,
Uta-Maria Bauer,
and Andreas Neubauer
|
22423-22435 |
PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer
PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancer |
https://doi.org/10.18632/oncotarget.25091
Oliver C. Rogers,
Lizamma Anthony,
D. Marc Rosen,
W. Nathaniel Brennen,
and Samuel R. Denmeade
|
22436-22450 |
Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses
Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses |
https://doi.org/10.18632/oncotarget.25121
Qingda Meng,
Davide Valentini,
Martin Rao,
Zhenjiang Liu,
Shanshan Xie,
Ann Morgell,
Ernest Dodoo,
Matthias Löhr,
Elena Rangelova,
Marco del Chiaro,
Ingemar Ernberg,
and Markus Maeurer
|
22451-22459 |
Somatic mutations in early onset luminal breast cancer
Somatic mutations in early onset luminal breast cancer |
https://doi.org/10.18632/oncotarget.25123
Giselly Encinas,
Veronica Y. Sabelnykova,
Eduardo Carneiro de Lyra,
Maria Lucia Hirata Katayama,
Simone Maistro,
Pedro Wilson Mompean de Vasconcellos Valle,
Gláucia Fernanda de Lima Pereira,
Lívia Munhoz Rodrigues,
Pedro Adolpho de Menezes Pacheco Serio,
Ana Carolina Ribeiro Chaves de Gouvêa,
Felipe Correa Geyer,
Ricardo Alves Basso,
Fátima Solange Pasini,
Maria del Pilar Esteves Diz,
Maria Mitzi Brentani,
João Carlos Guedes Sampaio Góes,
Roger Chammas,
Paul C. Boutros,
and Maria Aparecida Azevedo Koike Folgueira
|
22460-22479 |
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.25132
Shunsuke Itai,
Tomokazu Ohishi,
Mika K. Kaneko,
Shinji Yamada,
Shinji Abe,
Takuro Nakamura,
Miyuki Yanaka,
Yao-Wen Chang,
Shun-Ichi Ohba,
Yasuhiko Nishioka,
Manabu Kawada,
Hiroyuki Harada,
and Yukinari Kato
|
22480-22497 |
FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway
FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway |
https://doi.org/10.18632/oncotarget.25139
Suocheng Wei,
Xiaoyun Shen,
Luju Lai,
Haoqin Liang,
Yingying Deng,
Zhuandi Gong,
and Tuanjie Che
|
22498-22508 |
ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function
ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function |
https://doi.org/10.18632/oncotarget.25147
Igor Bado,
Eric Pham,
Benjamin Soibam,
Fotis Nikolos,
Jan-Åke Gustafsson,
and Christoforos Thomas
|
22509-22522 |
Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA
Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA |
https://doi.org/10.18632/oncotarget.25077
Martin Zaleski,
Makbule Kobilay,
Lars Schroeder,
Manuel Debald,
Alexander Semaan,
Karina Hettwer,
Steffen Uhlig,
Walther Kuhn,
Gunther Hartmann,
and Stefan Holdenrieder
|
22523-22536 |
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease
Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease |
https://doi.org/10.18632/oncotarget.25162
Stefanie Zschäbitz,
Florian A. Distler,
Benjamin Krieger,
Patrick Wuchter,
Kerstin Schäfer-Eckart,
Maximilian Jenzer,
Markus Hohenfellner,
Peter Dreger,
Georg Martin Haag,
Dirk Jäger,
Sascha Pahernik,
and Carsten Grüllich
|
22537-22545 |
Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction
Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction |
https://doi.org/10.18632/oncotarget.24547
Mengying Zhang,
Christian Saad,
Lien Le,
Kathrin Halfter,
Bernhard Bauer,
Ulrich R. Mansmann,
and Jian Li
|
22546-22558 |
Lung cancer in never smokers from the Princess Margaret Cancer Centre
Lung cancer in never smokers from the Princess Margaret Cancer Centre |
https://doi.org/10.18632/oncotarget.25176
Grzegorz J. Korpanty,
Suzanne Kamel-Reid,
Melania Pintilie,
David M. Hwang,
Alona Zer,
Geoffrey Liu,
Natasha B. Leighl,
Ronald Feld,
Lillian L. Siu,
Philippe L. Bedard,
Ming-Sound Tsao,
and Frances A. Shepherd
|
22559-22570 |
Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors
Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors |
https://doi.org/10.18632/oncotarget.25181
Elliot John Kahen,
Andrew Brohl,
Diana Yu,
Darcy Welch,
Christopher L. Cubitt,
Jae K. Lee,
Yunyun Chen,
Sean J. Yoder,
Jamie K. Teer,
Yonghong O. Zhang,
Margaret R. Wallace,
and Damon R. Reed
|
22571-22585 |
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers |
https://doi.org/10.18632/oncotarget.25187
Sylvie Maubant,
Tania Tahtouh,
Amélie Brisson,
Virginie Maire,
Fariba Némati,
Bruno Tesson,
Mengliang Ye,
Guillem Rigaill,
Maïté Noizet,
Aurélie Dumont,
David Gentien,
Bérengère Marty-Prouvost,
Leanne de Koning,
Sardar Faisal Mahmood,
Didier Decaudin,
Francisco Cruzalegui,
Gordon C. Tucker,
Sergio Roman-Roman,
and Thierry Dubois
|
22586-22604 |
Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations
Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations |
https://doi.org/10.18632/oncotarget.25194
Emilee Senkevitch,
Wenqing Li,
Julie A. Hixon,
Caroline Andrews,
Sarah D. Cramer,
Gary T. Pauly,
Timothy Back,
Kelli Czarra,
and Scott K. Durum
|
22605-22617 |
A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle
A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle |
https://doi.org/10.18632/oncotarget.25200
Haynes Shek Hei Yuan,
Sachin Katyal,
and Judy E. Anderson
|
22618-22630 |
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib
The role of netrin-1 in metastatic renal cell carcinoma treated with sunitinib |
https://doi.org/10.18632/oncotarget.25201
Sebastian Frees,
Betty Zhou,
Kyung Seok Han,
Zheng Tan,
Peter Raven,
Alexander Wong,
Ninadh D’Costa,
Ladan Fazli,
Werner Struss,
Igor Moskalev,
Claudia Chavez-Munoz,
and Alan So
|
22631-22641 |
Polyomaviruses detectable in head and neck carcinomas
Polyomaviruses detectable in head and neck carcinomas |
https://doi.org/10.18632/oncotarget.25202
Leonard Poluschkin,
Jaana Rautava,
Aaro Turunen,
Yilin Wang,
Klaus Hedman,
Kari Syrjänen,
Reidar Grenman,
and Stina Syrjänen
|
22642-22652 |
Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?
Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids? |
https://doi.org/10.18632/oncotarget.25203
Georgios A. Kanakis,
Lars Grimelius,
Dimitrios Papaioannou,
Gregory Kaltsas,
and Apostolos V. Tsolakis
|
22653-22664 |
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma |
https://doi.org/10.18632/oncotarget.25205
Laura L. Stafman,
Smitha Mruthyunjayappa,
Alicia M. Waters,
Evan F. Garner,
Jamie M. Aye,
Jerry E. Stewart,
Karina J. Yoon,
Kimberly Whelan,
Elizabeth Mroczek-Musulman,
and Elizabeth A. Beierle
|
22665-22679 |
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells
Effect of the monoclonal antibody TRC105 in combination with Sunitinib on renal tumor derived endothelial cells |
https://doi.org/10.18632/oncotarget.25206
Alessia Brossa,
Lola Buono,
and Benedetta Bussolati
|
22680-22692 |
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel |
https://doi.org/10.18632/oncotarget.25209
J. Tyson McDonald,
Athena Kritharis,
Afshin Beheshti,
Monika Pilichowska,
Kristine Burgess,
Luisel Ricks-Santi,
Elizabeth McNiel,
Cheryl A. London,
Dashnamoorthy Ravi,
and Andrew M. Evens
|
22693-22702 |
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro |
https://doi.org/10.18632/oncotarget.25210
Abigail Kora Suwala,
Katharina Koch,
Dayana Herrera Rios,
Philippe Aretz,
Constanze Uhlmann,
Isabella Ogorek,
Jörg Felsberg,
Guido Reifenberger,
Karl Köhrer,
René Deenen,
Hans-Jakob Steiger,
Ulf D. Kahlert,
and Jaroslaw Maciaczyk
|
22703-22716 |
Parenclitic networks for predicting ovarian cancer
Parenclitic networks for predicting ovarian cancer |
https://doi.org/10.18632/oncotarget.25216
Harry J. Whitwell,
Oleg Blyuss,
Usha Menon,
John F. Timms,
and Alexey Zaikin
|
22717-22726 |
Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma
Bcl6/p53 expression, macrophages/mast cells infiltration and microvascular density in invasive breast carcinoma |
https://doi.org/10.18632/oncotarget.25220
Roberto Tamma,
Simona Ruggieri,
Tiziana Annese,
Giovanni Simone,
Anita Mangia,
Serena Rega,
Francesco A. Zito,
Beatrice Nico,
and Domenico Ribatti
|
22727-22740 |
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcoma |
https://doi.org/10.18632/oncotarget.25228
Sebastian J. Schober,
Irene von Luettichau,
Angela Wawer,
Maximilian Steinhauser,
Christoph Salat,
Wolfgang Schwinger,
Marek Ussowicz,
Petar Antunovic,
Luca Castagna,
Hans-Jochem Kolb,
Stefan EG Burdach,
and Uwe Thiel
|
22741-22748 |
Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing
Simultaneous identification of clinically relevant single nucleotide variants, copy number alterations and gene fusions in solid tumors by targeted next-generation sequencing |
https://doi.org/10.18632/oncotarget.25229
Duarte Mendes Oliveira,
Teresa Mirante,
Chiara Mignogna,
Marianna Scrima,
Simona Migliozzi,
Gaetano Rocco,
Renato Franco,
Francesco Corcione,
Giuseppe Viglietto,
Donatella Malanga,
and Antonia Rizzuto
|
22749-22768 |
Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer
Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer |
https://doi.org/10.18632/oncotarget.25232
Yuhei Kogata,
Tomohito Tanaka,
Yoshihiro J. Ono,
Masami Hayashi,
Yoshito Terai,
and Masahide Ohmichi
|
22769-22784 |
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma |
https://doi.org/10.18632/oncotarget.25237
Stefania Augeri,
Stefania Capano,
Simona Morone,
Giulia Fissolo,
Alice Giacomino,
Silvia Peola,
Zahida Drace,
Ida Rapa,
Silvia Novello,
Marco Volante,
Luisella Righi,
Enza Ferrero,
Erika Ortolan,
and Ada Funaro
|
22785-22801 |
CNS cancer immunity cycle and strategies to target this for glioblastoma
CNS cancer immunity cycle and strategies to target this for glioblastoma |
https://doi.org/10.18632/oncotarget.24896
Malaka Ameratunga,
Niamh Coleman,
Liam Welsh,
Frank Saran,
and Juanita Lopez
|
22802-22816 |
Lamins and bone disorders: current understanding and perspectives
Lamins and bone disorders: current understanding and perspectives |
https://doi.org/10.18632/oncotarget.25071
Chiara Gargiuli,
Elisa Schena,
Elisabetta Mattioli,
Marta Columbaro,
Maria Rosaria D'Apice,
Giuseppe Novelli,
Tiziana Greggi,
and Giovanna Lattanzi
|
22817-22831 |
Role of tumor microenvironment in ovarian cancer pathobiology
Role of tumor microenvironment in ovarian cancer pathobiology |
https://doi.org/10.18632/oncotarget.25126
Alia Ghoneum,
Hesham Afify,
Ziyan Salih,
Michael Kelly,
and Neveen Said
|
22832-22849 |
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review |
https://doi.org/10.18632/oncotarget.25230
Maria Lopez-Santillan,
Ane Larrabeiti-Etxebarria,
Javier Arzuaga-Mendez,
Elixabet Lopez-Lopez,
and Africa Garcia-Orad
|
22850-22861 |
Micromolecular methods for diagnosis and therapeutic strategy: a case study
Micromolecular methods for diagnosis and therapeutic strategy: a case study |
https://doi.org/10.18632/oncotarget.25161
Morad Elbouchtaoui,
Iulia Tengher,
Catherine Miquel,
Charlotte Brugière,
Amélie Benbara,
Laurent Zelek,
Marianne Ziol,
Fatiha Bouhidel,
Anne Janin,
Guilhem Bousquet,
and Christophe Leboeuf
|
22862-22869 |
Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation
Correction: Mitochondrial clearance by the STK38 kinase supports oncogenic Ras-induced cell transformation |
https://doi.org/10.18632/oncotarget.25335
Audrey Bettoun,
Carine Joffre,
Giulia Zago,
Didier Surdez,
David Vallerand,
Ramazan Gundogdu,
Ahmad A.D. Sharif,
Marta Gomez,
Ilaria Cascone,
Brigitte Meunier,
Michael A. White,
Patrice Codogno,
Maria Carla Parrini,
Jacques H. Camonis,
and Alexander Hergovich
|
22870-22870 |
Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells
Correction: Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells |
https://doi.org/10.18632/oncotarget.25336
Nathan De Beule,
Eline Menu,
Mathieu J.M. Bertrand,
Mérédis Favreau,
Elke De Bruyne,
Ken Maes,
Kim De Veirman,
Magdalena Radwanska,
Afshin Samali,
Stefan Magez,
Karin Vanderkerken,
and Carl De Trez
|
22871-22871 |